Literature DB >> 28729353

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Alan Daugherty, Alan R Tall, Mat J A P Daemen, Erling Falk, Edward A Fisher, Guillermo García-Cardeña, Aldons J Lusis, A Phillip Owens, Michael E Rosenfeld, Renu Virmani.   

Abstract

Animal studies are a foundation for defining mechanisms of atherosclerosis and potential targets of drugs to prevent lesion development or reverse the disease. In the current literature, it is common to see contradictions of outcomes in animal studies from different research groups, leading to the paucity of extrapolations of experimental findings into understanding the human disease. The purpose of this statement is to provide guidelines for development and execution of experimental design and interpretation in animal studies. Recommendations include the following: (1) animal model selection, with commentary on the fidelity of mimicking facets of the human disease; (2) experimental design and its impact on the interpretation of data; and (3) standard methods to enhance accuracy of measurements and characterization of atherosclerotic lesions.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; animal models; atherosclerosis; cholesterol; histology; pathology

Mesh:

Year:  2017        PMID: 28729353     DOI: 10.1161/RES.0000000000000169

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

Authors:  Qing Wu; Lulu Sun; Xiaomin Hu; Xuemei Wang; Feng Xu; Bo Chen; Xianyi Liang; Jialin Xia; Pengcheng Wang; Daisuke Aibara; Shaofei Zhang; Guangyi Zeng; Chuyu Yun; Yu Yan; Yicheng Zhu; Michael Bustin; Shuyang Zhang; Frank J Gonzalez; Changtao Jiang
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 2.  IGF-1 and cardiovascular disease.

Authors:  Yusuke Higashi; Sandeep Gautam; Patrick Delafontaine; Sergiy Sukhanov
Journal:  Growth Horm IGF Res       Date:  2019-01-31       Impact factor: 2.372

3.  Basic research: Standardizing animal atherosclerosis studies to improve reproducibility.

Authors:  Oliver Soehnlein; Carlos Silvestre-Roig
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

4.  Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice.

Authors:  Sidney Mahan; Mingjun Liu; Richard A Baylis; Delphine Gomez
Journal:  J Vis Exp       Date:  2019-02-20       Impact factor: 1.355

5.  Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.

Authors:  Kelsey E Jarrett; Ciaran Lee; Marco De Giorgi; Ayrea Hurley; Baiba K Gillard; Alexandria M Doerfler; Ang Li; Henry J Pownall; Gang Bao; William R Lagor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

6.  Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.

Authors:  Alison C Kearns; Stephani Velasquez; Fengming Liu; Shen Dai; Yong Chen; Gabrielle Lehmicke; Jennifer Gordon; Jay Rappaport; Xuebin Qin
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.177

7.  Atherosclerosis Induced by Adeno-Associated Virus Encoding Gain-of-Function PCSK9.

Authors:  Martin Mæng Bjørklund; Juan A Bernal; Jacob F Bentzon
Journal:  Methods Mol Biol       Date:  2022

Review 8.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

9.  Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Anh T P Ngo; Kelley R Jordan; Paul A Mueller; Matthew W Hagen; Stéphanie E Reitsma; Cristina Puy; Alexey S Revenko; Christina U Lorentz; Erik I Tucker; Quifang Cheng; Monica T Hinds; Sergio Fazio; Brett P Monia; David Gailani; András Gruber; Hagai Tavori; Owen J T McCarty
Journal:  J Thromb Haemost       Date:  2021-02-10       Impact factor: 5.824

10.  Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.

Authors:  Yuhao Liu; Ying Zhao; Yousef Shukha; Haocheng Lu; Lu Wang; Zhipeng Liu; Cai Liu; Yang Zhao; Huilun Wang; Guizhen Zhao; Wenying Liang; Yanbo Fan; Lin Chang; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr; Michael Aviram; Bo Wen; Minerva T Garcia-Barrio; Jifeng Zhang; Wanqing Liu; Duxin Sun; Tony Hayek; Y Eugene Chen; Oren Rom
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.